Blog

May 10, 2022

On Longevity Escape Velocity with Aubrey de Grey & Charles Brenner

Posted by in categories: biotech/medical, life extension

For our inaugural episode of Let’s Talk Longevity, we want to figure out if we are anywhere near Longevity Escape Velocity. Defined as a hypothetical situation in which life expectancy is extended longer than the time that is passing, we decided the best conversation on it would be with its biggest advocate, Dr. Aubrey de Grey, and an equally well-known skeptic of the likelihood of it taking place, Dr. Charles Brenner. This debate did not need hosts!

Join us for the live Q&A on Twitter Spaces this Thursday, May 12th at 12 pm PDT
https://twitter.com/i/spaces/1ypKdEmgDANGW

Also available on Apple Podcasts:
https://podcasts.apple.com/us/podcast/lets-talk-longevity/id1623103254

Our sponsors.
Methuselah Foundation https://www.mfoundation.org/
The Methuselah Foundation is a non-profit medical charity focused on extending the healthy human lifespan by making 90 the new 50 by 2030.

MYKIGAI: https://mykigai.substack.com/letstalklongevity.
Discovery & Recommendation platform for longevity.

Social & Website.
Website-https://www.letstalklongevity.com/
Twitter — https://twitter.com/longevitytalk.
Newsletter — https://letstalklongevity.substack.com/

Guests.
Dr. Aubrey de Grey is a biomedical gerontologist based in Mountain View, California, USA. He received his BA in computer science and Ph.D. in biology from the University of Cambridge. His research interests encompass the characterization of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage. Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Aging Association and sits on the editorial and scientific advisory boards of numerous journals and organizations. He is a highly sought-after speaker who gives 40–50 invited talks per year at scientific conferences, universities, and companies in areas ranging from pharma to life insurance, and to the public.
Twitter — https://twitter.com/aubreydegrey.

Comments are closed.